10 years of success in drug discovery and renewed funding from governments

Montreal, October 24, 2018 – IRICoR celebrated, on Monday, 10 years of success in drug discovery and renewed funding from governments. For the occasion, we had a very interesting panel on artificial intelligence and drug discovery which led to a rich discussion between our four panelists: Pierre Côte, Therence Bois, Sébastien Lemieux and Jean-Sébastien Cournoyer. A real success!
Thanks to […]

IRICoR to present at the LES workshop – Montreal Chapter

Laval, October 09, 2018 – Dr. Steven Klein, Vice-President Business Development at IRICoR is a guest speaker today,  at the Licensing Executives Society workshop to held at Servier canada inc.
The conference will be entitled “Biotechnology & Pharma Companies: “Facing the challenges in oncology: The North American and French Perspective” »”. Oncology appears today as the most difficult challenging therapeutic area from both scientific […]

Symposium : Artificial Intelligence + Drug Discovery

On the next October 22, IRICoR invites you to participate in a roundtable featuring four leaders from research, business and industry who will share a new vision for generating the therapeutic solutions of tomorrow.


When: Monday, October 22, 2018 at 5 pm
Where: Agora Morris and Rosalind Goodman, Marcelle Coutu Pavilion

This will be followed by a cocktail celebrating 10 years of IRICoR’s […]

Invited speaker – International Congress on Personalized Health Care 2018

Nadine Beauger, Chief Executive Officer of IRICoR, participated, this Monday, to the 2nd edition of the International Congress on Personalized Health Care (ICPHC2018) organized by The Quebec Network for Personalized Health Care (QNPHC) to present the innovative business model of IRICoR at the « Innovative Technologies in “OMICS” Applications » session.
As Université de Montréal’s drug discovery and project […]

Launch of the LeadAction-Onco Competition

Montreal, September 20, 2018 – IRICoR is proud to launch, today with the Oncopole, this new LeadAction-Onco Competition. This joint call for projects, in partnership with the FRQS, is an opportunity for researchers from Quebec and the rest of Canada to accelerate the transformation of their projects in oncology and immuno-oncology into novel therapies […]

Nadine Beauger and Steven Klein look back on 10 years of success, in the magazine BioTechnology Focus

Dr. Nadine Beauger, Chief Executive Director and Dr. Steven Klein, Vice President, Business Development at IRCoR, took part in a Q&A session to discuss the key strengths and benefits of IRICoR’s model, its achievements and the partnerships created over the past 10 years, as well as the organization’s vision for the next 5 years, in the August-September 2018 edition of […]

IRICoR receives 25 million dollars to support its research commercialization activities as part of the 2018 CECR competition

Montreal, July 30, 2018 — IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence for Commercialization and Research program […]

IRICoR and Université de Montréal Enter into Research Collaboration with AbbVie to Discover Tumor-Specific Neoantigens

Montreal, June 5, 2018 – The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) and its host institution, the Université de Montréal (UdeM) today announced that they have entered into a research collaboration with AbbVie, a global research and development-driven biopharmaceutical company, in order to identify Tumor-Specific Neoantigens (TSNA) based on a novel proprietary platform developed […]

IRICoR takes part in a life sciences mission organized by the Government of Quebec in Belgium

In collaboration with the Québec Government Office in Brussels, the Minister of Economy, Science and Innovation (MESI), organizes an economic mission in research in innovation in the life sciences sector, happening from May 14th to 17th 2018. Nadine Beauger, Chief Executive Officer of IRICoR is a member of the delegation.
This mission will allow the attending Quebec organizations to take […]

CHU Ste-Justine’s Quality & Innovation Week – Nadine Beauger invited Speaker

As part of CHU Ste-Justine’s Quality & Innovation Week, Nadine Beauger, IRICoR’s Executive Director, shared her experience and her career as a woman and scientist in the business world, at the Entrepreunariat Career Evening as guest speaker.

The “Entrepreunariat” career evening was held during a journey under the theme Personalized Health and highlighted promising initiatives and new targeted health solutions.
As Université […]

« Previous Page | Next Page »